journal article·2014-11-12Open access

A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins

Won Il Choi, Nazila Kamaly, Lorena Riol-Blanco, In-Hyun Lee, Jun Wu, Archana Swami, Cristian Vilos, Basit Yameen, Mikyung Yu, Jinjun Shi, Ira Tabas, Ulrich H. von Andrian, Sangyong Jon, Omid C. Farokhzad

Nano Letters· Volume 14· Issue 11

Abstract

Protein therapeutics have gained attention recently for treatment of a myriad of human diseases due to their high potency and unique mechanisms of action. We present the development of a novel polymeric thermosponge nanoparticle for efficient delivery of labile proteins using a solvent-free polymer thermo-expansion mechanism with clinical potential, capable of effectively delivering a range of therapeutic proteins in a sustained manner with no loss of bioactivity, with improved biological half-lives and efficacy in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital and ‡Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston, Massachusetts 02115, United States

Center for Integrative Medicine and Innovative Science, Faculty of Medicine, Universidad Andres Bello, Santiago, Chile

Department of Medicine, ⊥Department of Pathology and Cell Biology, and #Department of Physiology, Columbia University, New York, New York 10032, United States

KAIST Institute of the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea

King Abdulaziz University, Jeddah 21589, Saudi Arabia

Funding

National Heart, Lung, and Blood Institute · National Cancer Institute · Prostate Cancer Foundation · National Institute of Biomedical Imaging and Bioengineering

References (45)

Show source-provided references
1. Bi R. · J. Biomed. Nanotechnol. · 2009 · 5 · 8410.1166/jbn.2009.036 ↗
2. Smola M. · Int. J. Nanomed. · 2008 · 3 · 110.2217/17435889.3.1.1 ↗
3. Kammona O. · J. Controlled Release · 2012 · 161 · 78110.1016/j.jconrel.2012.05.040 ↗
4. Chung S. W. · J. Drug. Target. · 2012 · 20 · 48110.3109/1061186X.2012.693499 ↗
5. Pridgen E. M. · Sci. Transl. Med. · 2013 · 5 · 213ra16710.1126/scitranslmed.3007049 ↗
6. Bakhru S. H. · Adv. Drug Delivery Rev. · 2013 · 65 · 81110.1016/j.addr.2013.04.006 ↗
7. Kamei N. · Ther. Delivery · 2013 · 4 · 31510.4155/tde.12.164 ↗
8. Sinclair A. M. · J. Pharm. Sci. · 2005 · 94 · 162610.1002/jps.20319 ↗
9. Jain S. · Biochim. Biophys. Acta · 2003 · 1622 · 4210.1016/S0304-4165(03)00116-8 ↗
10. Baslé E. · Chem. Biol. · 2010 · 17 · 21310.1016/j.chembiol.2010.02.008 ↗
11. Harris J. M. · Nat. Rev. Drug Discovery · 2003 · 2 · 21410.1038/nrd1033 ↗
12. Bailon P. · Pharm. Sci. Technol. Today · 1998 · 1 · 35210.1016/S1461-5347(98)00086-8 ↗
13. Constantinides P. P. · Adv. Drug Delivery Rev. · 2004 · 56 · 123910.1016/j.addr.2004.02.002 ↗
14. Martins S. · Int. J. Nanomedicine · 2007 · 2 · 595
15. Utama R. H. · Chem. Commun. · 2012 · 48 · 1110310.1039/c2cc36116g ↗
16. Kamaly N. · Chem. Soc. Rev. · 2012 · 41 · 297110.1039/c2cs15344k ↗
17. Hasadsri L. · J. Biol. Chem. · 2009 · 284 · 697210.1074/jbc.M805956200 ↗
18. Moghimi S. M. · ACS Nano · 2011 · 5 · 845410.1021/nn2038252 ↗
19. Kobsa S. · Pediatr. Res. · 2008 · 63 · 51310.1203/PDR.0b013e318165f14d ↗
20. Yan M. · Nat. Nanotechnol. · 2010 · 5 · 4810.1038/nnano.2009.341 ↗
21. Zhang F. · Biol. Pharm. Bull. · 2014 · 37 · 33510.1248/bpb.b13-00661 ↗
22. Pisal D. S. · J. Pharm. Sci. · 2010 · 99 · 255710.1002/jps.22054 ↗
23. Soppimath K. S. · J. Controlled Release · 2001 · 70 · 110.1016/S0168-3659(00)00339-4 ↗
24. Choi W. I. · J. Mater. Chem. · 2008 · 18 · 276910.1039/b801262h ↗
25. Tabas I. · Science · 2013 · 339 · 16610.1126/science.1230720 ↗
26. Keystone E. · Rheum. Dis. Clin. North Am. · 1998 · 24 · 62910.1016/S0889-857X(05)70030-2 ↗
27. Long D. L. · Exp. Hematol. · 2006 · 34 · 69710.1016/j.exphem.2006.02.011 ↗
28. Choi W. I. · Biomacromolecules · 2008 · 9 · 169810.1021/bm701391b ↗
29. Chang L. P. · J. Pharmacol. Sci. · 2009 · 111 · 14710.1254/jphs.09043FP ↗
30. Hernández-Ledesma B. · Biochem. Biophys. Res. Commun. · 2009 · 390 · 80310.1016/j.bbrc.2009.10.053 ↗
31. Kim J. Y. · J. Controlled Release · 2011 · 156 · 39810.1016/j.jconrel.2011.07.017 ↗
32. Dokka S. · Am. J. Physiol. Lung Cell Mol. Physiol. · 2001 · 280 · L119610.1152/ajplung.2001.280.6.L1196 ↗
33. Carl V. S. · J. Leukocyte Biol. · 2004 · 76 · 73510.1189/jlb.1003526 ↗
34. Capiralla H. · FEBS J. · 2012 · 279 · 379110.1111/j.1742-4658.2012.08739.x ↗
35. Chappell J. · J. Biol. Chem. · 2001 · 276 · 3802310.1074/jbc.M104416200 ↗
36. Schwarz A. · J. Invest. Dermatol. · 1994 · 103 · 21110.1111/1523-1747.ep12393073 ↗
37. Heinemann L. · Expert. Opin. Biol. Ther. · 2012 · 12 · 100910.1517/14712598.2012.688024 ↗
38. Orive G. · Curr. Opin. Biotechnol. · 2003 · 14 · 65910.1016/j.copbio.2003.10.007 ↗
39. Schmidt F. R. · Appl. Microbiol. Biotechnol. · 2004 · 65 · 36310.1007/s00253-004-1656-9 ↗
40. Johnson O. L. · Nat. Med. · 1996 · 2 · 79510.1038/nm0796-795 ↗
41. Kim A. · Int. J. Pharm. · 1999 · 180 · 7510.1016/S0378-5173(98)00408-6 ↗
42. Kanaoka E. · J. Pharm. Pharmacol. · 2001 · 53 · 29510.1211/0022357011775523 ↗
43. Alvarez H. M. · Drug Metab. Dispos. · 2012 · 40 · 36010.1124/dmd.111.042531 ↗
44. Chan Y. P. · Expert Opin. Drug Delivery · 2007 · 4 · 44110.1517/17425247.4.4.441 ↗
45. Gan Q. · Colloids Surf., B · 2007 · 59 · 2410.1016/j.colsurfb.2007.04.009 ↗